Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions

: Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days - JSON Representation

Raw json | Download


{
  "resourceType" : "Group",
  "id" : "179783",
  "meta" : {
    "versionId" : "3",
    "lastUpdated" : "2023-12-04T20:29:22.185Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-definition"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Group</b><a name=\"179783\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Group &quot;179783&quot; Version &quot;3&quot; Updated &quot;2023-12-04 20:29:22+0000&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-exposure-definition.html\">ExposureDefinition</a></p></div><p><b>Artifact related artifact</b>: </p><p><b>Artifact Title</b>: Remdesivir IV 200 mg once then 100 mg once daily for 9 days</p><p><b>Artifact URL</b>: <a href=\"https://fevir.net/resources/Group/179783\">https://fevir.net/resources/Group/179783</a></p><p><b>Artifact Publisher</b>: Computable Publishing LLC</p><p><b>Artifact Copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>Artifact Contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>Artifact Author</b>: Brian S. Alper: </p><blockquote><p><b>modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]</b></p></blockquote><p><b>identifier</b>: FEvIR Object Identifier:\u00a0179783</p><p><b>type</b>: animal</p><p><b>membership</b>: definitional</p><p><b>name</b>: Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days</p><p><b>description</b>: Remdesivir IV 200 mg once then 100 mg once daily for 9 days</p><h3>Characteristics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Extension</b></td><td><b>Code</b></td><td><b>Value[x]</b></td><td><b>Exclude</b></td></tr><tr><td style=\"display: none\">*</td><td/><td>Defined by Reference <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></td><td><a href=\"ActivityDefinition-213.html\">ActivityDefinition/213: IV remdesivir 200 mg then 100 mg/day for 9 days</a> &quot;IV_remdesivir_200_mg_then_100_mg_day_for_9_days&quot;</td><td>false</td></tr></table></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
      "valueRelatedArtifact" : {
        "type" : "cite-as",
        "citation" : "Remdesivir IV 200 mg once then 100 mg once daily for 9 days [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179783. Revised 2023-11-30. Available at: https://fevir.net/resources/Group/179783. Computable resource at: https://fevir.net/resources/Group/179783."
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-title",
      "valueString" : "Remdesivir IV 200 mg once then 100 mg once daily for 9 days"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-url",
      "valueUri" : "https://fevir.net/resources/Group/179783"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-publisher",
      "valueString" : "Computable Publishing LLC"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-copyright",
      "valueMarkdown" : "https://creativecommons.org/licenses/by-nc-sa/4.0/"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-contact",
      "valueContactDetail" : {
        "telecom" : [
          {
            "system" : "email",
            "value" : "support@computablepublishing.com"
          }
        ]
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail" : {
        "name" : "Brian S. Alper"
      }
    }
  ],
  "modifierExtension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-status",
      "valueCode" : "active"
    }
  ],
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "https://fevir.net",
      "value" : "179783",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "type" : "animal",
  "membership" : "definitional",
  "name" : "Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days",
  "description" : "Remdesivir IV 200 mg once then 100 mg once daily for 9 days",
  "characteristic" : [
    {
      "extension" : [
        {
          "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description",
          "valueMarkdown" : "Remdesivir IV 200 mg once then 100 mg once daily for 9 days"
        }
      ],
      "code" : {
        "text" : "Defined by Reference"
      },
      "valueReference" : {
        🔗 "reference" : "ActivityDefinition/213",
        "type" : "ActivityDefinition",
        "display" : "IV remdesivir 200 mg then 100 mg/day for 9 days"
      },
      "exclude" : false
    }
  ]
}